ArticleCureus2025
Homozygous Familial Hypercholesterolemia in a Seven-Year-Old: A Case Study Highlighting the Importance of Early Diagnosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Familial hypercholesterolemia (FH) is a common autosomal dominant disorder characterized by markedly elevated low-density lipoprotein (LDL)-cholesterol levels and an increased risk of premature cardiovascular disease. The homozygous form, which is much rarer and more severe, manifests in early childhood with extremely high LDL-cholesterol levels and early-onset atherosclerosis. We report the case of a seven-year-old girl, born to consanguineous parents, presenting with tuberous and tendinous xanthomas. Her lipid profile revealed severe hypercholesterolemia (total cholesterol: 7.5 g/L; LDL-C: 6.82 g/L), low high-density lipoprotein-cholesterol (HDL-C) (0.29 g/L), and normal triglycerides. Echocardiography showed atheromatous lesions in the aortic arch. Molecular analysis identified a pathogenic homozygous mutation in the LDLR gene. Treatment with atorvastatin followed by ezetimibe was initiated, along with dietary and lifestyle modifications. Follow-up showed moderate regression of the atheromatous lesions. A six-month follow-up plan was established, and LDL apheresis was considered. This case highlights the importance of early screening, genetic confirmation, and intensive multidisciplinary management to prevent premature cardiovascular complications in children with homozygous familial hypercholesterolemia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.